Targeting ErbB Receptors in High-Grade Glioma

E-ISSN： 1873-4286|17|23|2468-2487

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.23, 2011-08, pp. : 2468-2487

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The ErbB Receptors and their Ligands in Cancer: An Overview

Current Drug Targets, Vol. 6, Iss. 3, 2005-05 ,pp. : 243-257

Bentham Science Publishers

Access to resources Recommend Favorite

Current and future directions for Phase II trials in high-grade glioma

By Alexander Brian M Lee Eudocia Q Reardon David A Wen Patrick Y

Expert Review of Neurotherapeutics, Vol. 13, Iss. 4, 2013-04 ,pp. : 369-387

Informa Healthcare

Access to resources Recommend Favorite

Cytotoxic and molecular chemotherapy for high-grade glioma: an emerging strategy for the future

By Cavaliere Robert Newton Herbert

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 749-765

Informa Healthcare

Access to resources Recommend Favorite

Carmustine-impregnated wafers and their impact in the management of high-grade glioma

By La Rocca Renato V Rezazadeh Arash

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 8, 2011-06 ,pp. : 1325-1332

Informa Healthcare

Access to resources Recommend Favorite

Increasing complexity of high-grade B-cell lymphomas

By Armitage James O. Bociek R. Gregory

Cancer, Vol. 120, Iss. 11, 2014-06 ,pp. : 1611-1613

Blackwell Publishing

Access to resources Recommend Favorite